Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|January 1, 1997
Supplements and Featured Publications
- Managing Hypercholesterolemia and Coronary Heart Disease
- Volume 3
- Issue 1 Suppl
Pharmacoeconomics: The Cost Effectiveness of Lipid Management
Advertisement
Articles in this issue
over 29 years ago
MCO Decisions and Solutionsover 29 years ago
The Importance of Lipid Lowering and Other Risk Reduction Therapiesover 29 years ago
Matching Risks to Interventions: When to Treat, How to Treatover 29 years ago
CME Quizover 29 years ago
Bibliographyover 29 years ago
Participantsover 29 years ago
Goals and Objectivesover 29 years ago
Introductionover 29 years ago
Goals for Patient TreatmentAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Novel Iberdomide Regimen in RRMM
2
Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD
3
AI Model Outperforms Apnea-Hypopnea Index in Predicting Sleep Apnea Mortality Risk
4
IL-17 Signaling Bridges Psoriasis and Cardiometabolic Risk, Review Finds
5